Irreversible Electroporation Balloon Therapy for Palliative Treatment of Obstructive Urethral Transitional Cell Carcinoma in Dogs
Journal of the American Animal Hospital Association · 2022-09 · 58 (5) · 231-239
DOI: 10.5326/jaaha-ms-7160 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Animal Hospital Association, 2022-09. Verfasst von Emmanuelle Marie Butty und 2 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Clinical Sciences, Small Animal Internal Medicine, Cummings School of Veterinary Medicine at Tufts University, North Grafton, …. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Dog Diseases, Urethral Obstruction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Progression of transitional cell carcinoma (TCC) in dogs often leads to urinary obstruction. This observational pilot study aimed to evaluate the safety and efficacy of irreversible electroporation (IRE) balloon therapy for the palliative treatment of TCC with partial urethral obstruction. Three client-owned dogs diagnosed with TCC causing partial urethral obstruction were enrolled. After ultrasonographic and cystoscopic examination, IRE pulse protocols were delivered through a balloon catheter device inflated within the urethral lumen. After the procedure, the patients were kept overnight for monitoring and a recheck was planned 28 days later. No complication was observed during the procedure and postprocedural monitoring. After 28 days, one dog had a complete normalization of the urine stream, one dog had stable stranguria, and one dog was presented with a urethral obstruction secondary to progression of the TCC. On recheck ultrasound, one dog had a 38% diminution of the urethral mass diameter whereas the other two dogs had a mass stable in size. IRE balloon therapy seems to be a feasible and apparently safe minimally invasive novel therapy for the palliative treatment of TCC causing urethral obstruction. Further studies are needed to better characterize the safety, efficacy, and outcome of this therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Department of Clinical Sciences, Small Animal Internal Medicine, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts (E.M.B., M.A.L.).
- Research and Development Interventional Oncology, Boston Scientific Corporation, Marlborough, Massachusetts (B.F.).
Zitieren
APA
Marie Butty, E., Forsyth, B., & Labato, M. A. (2022). Irreversible Electroporation Balloon Therapy for Palliative Treatment of Obstructive Urethral Transitional Cell Carcinoma in Dogs. Journal of the American Animal Hospital Association, 58(5), 231-239. https://doi.org/10.5326/jaaha-ms-7160
Vancouver
Marie Butty E, Forsyth B, Labato MA. Irreversible Electroporation Balloon Therapy for Palliative Treatment of Obstructive Urethral Transitional Cell Carcinoma in Dogs. Journal of the American Animal Hospital Association. 2022;58(5):231-239. doi:10.5326/jaaha-ms-7160
BibTeX
@article{MarieButty2022,
author = {Marie Butty, Emmanuelle and Forsyth, Bruce and Labato, Mary Anna},
title = {Irreversible Electroporation Balloon Therapy for Palliative Treatment of Obstructive Urethral Transitional Cell Carcinoma in Dogs},
journal = {Journal of the American Animal Hospital Association},
year = {2022},
volume = {58},
number = {5},
pages = {231--239},
doi = {10.5326/jaaha-ms-7160}
}
EUVIMED